Product Catalog [{"id":"608","name":"Zaltrap","price":701.97,"sku":"Zaltrap (aflibercept)","brand":"Sanofi - Aventis Groupe","position":1,"category":"Medicines\/Oncology\/Colorectal Cancer"},{"id":"594","name":"Fruzaqla","price":10145.09,"sku":"Fruzaqla (fruquintinib)","brand":"Takeda Pharma A\/S","position":2,"category":"Medicines\/Oncology\/Colorectal Cancer"},{"id":"527","name":"Vegzelma ","price":769.57,"sku":"Vegzelma (bevacizumab-adcd)","brand":"Celltrion Healthcare Hungary Kft","position":3,"category":"Medicines\/Oncology\/Colorectal Cancer"},{"id":"169","name":"Braftovi","price":901.88,"sku":"Braftovi (encorafenib)","brand":" Pierre Fabre Medicament","position":4,"category":"Medicines\/Oncology\/Colorectal Cancer"},{"id":"148","name":"Xeloda","price":1,"sku":"Xeloda (capecitabine)","brand":"Genentech","position":5,"category":"Medicines\/Oncology\/Colorectal Cancer"},{"id":"64","name":"Cyramza","price":640.06,"sku":"Cyramza (ramucirumab)","brand":"Lilly","position":6,"category":"Medicines\/Oncology\/Colorectal Cancer"},{"id":"35","name":"Keytruda","price":4225.5,"sku":"Keytruda (pembrolizumab)","brand":"Merck Sharp ","position":7,"category":"Medicines\/Oncology\/Colorectal Cancer"},{"id":"32","name":"Lonsurf","price":810,"sku":"Lonsurf (trifluridine\/tipiracil)","brand":"Les Laboratoires Servier","position":8,"category":"Medicines\/Oncology\/Colorectal Cancer"},{"id":"21","name":"Opdivo","price":867.24,"sku":"Opdivo (nivolumab)","brand":"Bristol-Myers Squibb Pharma EEIG","position":9,"category":"Medicines\/Oncology\/Colorectal Cancer"}]

Colorectal Cancer access options

Globally, colorectal cancer is the third most common type of cancer making up about 10% of all cancer cases. In 2012 there were 1.4 million new cases and 694,000 deaths from colorectal cancer. The 5-year survival rates in the United States are around 65%. Colorectal cancer typically starts with a benign tumour. Colorectal cancer typically starts with a benign tumour, often in the form of a polyp, which over time becomes cancerous. Treatment options are depending on the stage of the disease, overall health and preferences of the patient. Standard treatments include surgery, chemotherapy, radiotherapy or a combination.
  1. Xeloda
    Xeloda
    Price available on request
  2. Braftovi
    Braftovi (encorafenib)
    Colorectal Cancer, Skin Cancer
    €901.88
  3. Vegzelma
    Vegzelma (bevacizumab-adcd)
    Colorectal Cancer, Gynaecological Cancer, Kidney Cancer, Liver Cancer, Lung Cancer
    €769.57
  4. Fruzaqla
    Fruzaqla (fruquintinib)
    Colorectal Cancer
    €10,145.09
  5. Zaltrap
    Zaltrap (aflibercept)
    Colorectal Cancer
    €701.97
  6. Opdivo
    Opdivo (Nivolumab)
    Urothelial Carcinoma, Colorectal Cancer, Head and Neck Cancer, Kidney Cancer, Liver Cancer, Lung Cancer, Lymphoma, Skin Cancer
    €867.24
  7. Lonsurf
    Lonsurf (trifluridine/tipiracil)
    Colorectal Cancer
    €810.00
  8. Keytruda
    Keytruda (pembrolizumab)
    Urothelial Carcinoma, Breast Cancer, Colorectal Cancer, Gastric Cancer, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Lymphoma, Skin Cancer
    €4,225.50
  9. Cyramza
    Cyramza (ramucirumab)
    Colorectal Cancer, Gastric Cancer, Lung Cancer
    €640.06
View as Grid List

9 Items

Set Descending Direction
Read more about the latest treatments in Colorectal Cancer
US United States 1